These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28733919)

  • 1. Substance Use, Violence, and Antiretroviral Adherence: A Latent Class Analysis of Women Living with HIV in Canada.
    Carter A; Roth EA; Ding E; Milloy MJ; Kestler M; Jabbari S; Webster K; de Pokomandy A; Loutfy M; Kaida A;
    AIDS Behav; 2018 Mar; 22(3):971-985. PubMed ID: 28733919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hunger, adherence to antiretroviral therapy and plasma HIV RNA suppression among HIV-positive illicit drug users in a Canadian setting.
    Anema A; Kerr T; Milloy MJ; Feng C; Montaner JS; Wood E
    AIDS Care; 2014 Apr; 26(4):459-65. PubMed ID: 24015838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Velloza J; Kemp CG; Aunon FM; Ramaiya MK; Creegan E; Simoni JM
    AIDS Behav; 2020 Jun; 24(6):1727-1742. PubMed ID: 31673913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance Use Stigma and Antiretroviral Therapy Adherence Among a Drug-Using Population Living with HIV.
    Stringer KL; Marotta P; Baker E; Turan B; Kempf MC; Drentea P; Stepanikova I; Turan JM
    AIDS Patient Care STDS; 2019 Jun; 33(6):282-293. PubMed ID: 31166784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.
    De Boni RB; Shepherd BE; Grinsztejn B; Cesar C; Cortés C; Padgett D; Gotuzzo E; Belaunzarán-Zamudio PF; Rebeiro PF; Duda SN; McGowan CC
    AIDS Behav; 2016 Nov; 20(11):2692-2699. PubMed ID: 27091028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
    AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in Kazakhstan.
    Mukherjee TI; Pala AN; Terlikbayeva A; Davis A; Howard AA; McCrimmon T; Mergenova G; Primbetova S; Witte SS; El-Bassel N
    Int J Drug Policy; 2022 Aug; 106():103750. PubMed ID: 35667193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users: A Latent Class Analysis.
    Shiu-Yee K; Brincks AM; Feaster DJ; Frimpong JA; Nijhawan A; Mandler RN; Schwartz R; Del Rio C; Metsch LR
    AIDS Behav; 2018 Sep; 22(9):2757-2765. PubMed ID: 29305761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.
    Azar P; Wood E; Nguyen P; Luma M; Montaner J; Kerr T; Milloy MJ
    BMC Infect Dis; 2015 Apr; 15():193. PubMed ID: 25927573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.
    Zhang Y; Wilson TE; Adedimeji A; Merenstein D; Milam J; Cohen J; Cohen M; Golub ET
    AIDS Behav; 2018 Mar; 22(3):896-908. PubMed ID: 28560499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
    Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
    AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Material security and adherence to antiretroviral therapy among HIV-positive people who use illicit drugs.
    Mohd Salleh NA; Van Draanen J; Nosova E; Barrios R; Milloy MJ; Richardson L
    AIDS; 2020 Jun; 34(7):1037-1045. PubMed ID: 32073444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Antiretroviral Adherence Self-efficacy Among People Living With HIV/AIDS in a Canadian Setting.
    Lee WK; Milloy MJS; Nosova E; Walsh J; Kerr T
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):103-109. PubMed ID: 30300214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of illicit drug use and substance abuse treatment on adherence to HAART.
    Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA;
    AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Impact of Hazardous and Harmful Use of Alcohol and/or Other Drugs on ARV Adherence and Disease Progression.
    Kader R; Govender R; Seedat S; Koch JR; Parry C
    PLoS One; 2015; 10(5):e0125088. PubMed ID: 25933422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpersonal violence and other social-structural barriers associated with needing HIV treatment support for women living with HIV.
    Erickson M; Shannon K; Ranville F; Magagula P; Braschel M; Ratzlaff A; Pick N; Kestler M; Deering On Behalf Of The Shawna Project K
    J Interpers Violence; 2022 Jun; 37(11-12):NP9926-NP9952. PubMed ID: 33403922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South.
    Tucker JA; Simpson CA; Huang J; Roth DL; Stewart KE
    AIDS Patient Care STDS; 2013 May; 27(5):280-6. PubMed ID: 23651105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherence.
    Paschen-Wolff MM; Campbell ANC; Tross S; Choo TH; Pavlicova M; Jarlais DD
    AIDS Care; 2020 May; 32(5):645-650. PubMed ID: 31682153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.